Used as an intermediate in the synthesis of pharmaceuticals and agrochemicals, particularly in cross-coupling reactions such as Suzuki or Heck reactions, where the bromo and iodo groups allow selective functionalization. The trifluoromethoxy group enhances lipophilicity and metabolic stability, making this compound valuable in the development of bioactive molecules, including potential drug candidates targeting central nervous system disorders and anti-inflammatory agents. It is also employed in materials science for constructing fluorinated organic semiconductors and liquid crystals due to its electron-withdrawing properties and structural rigidity.